Navigation Links
Abbott Annual Meeting Highlights Continued Strong Performance in 2009; Sustained Growth in 2010
Date:4/23/2010

ABBOTT PARK, Ill., April 23 /PRNewswire-FirstCall/ -- Abbott's (NYSE: ABT) diversified strategy continued to deliver superior growth and performance in 2009, Chairman and Chief Executive Officer Miles D. White told shareholders today at the company's annual meeting.  

"Abbott had another highly productive and successful year in 2009," said Mr. White.  "We delivered strong sales and earnings growth and took strategic actions to reshape our business portfolio for the long term, adding early- and late-stage pipeline technologies as well as new growth platforms."

Value of Diversity

Balanced performance across the company's major businesses and continued strong international growth drove a third consecutive year of double-digit ongoing earnings growth in 2009.  A majority of Abbott revenue was generated outside the U.S. for the third straight year, driven by growth across all businesses and strong performance within emerging markets in Asia, Eastern Europe and Latin America.  

Abbott has been a strong and solid long-term investment – significantly outperforming the major stock indices and the majority of its health care peers over the last three, five and 10 years.  Abbott's top-tier total return is a reflection of Abbott's stock price appreciation and dividend increases.  

"Abbott's diversified strategy has delivered years of superior growth and top-tier performance," said Mr. White.  "We are optimistic about the fundamental performance of our business with double-digit ongoing earning
'/>"/>

SOURCE Abbott
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. Abbott Receives Supplemental FDA Approval for its Best-in-Class in Sensitivity RealTime HIV-1 Viral Load Test
2. Abbott and AstraZeneca Announce Selection of Next-Generation Fenofibrate ABT-335 and CRESTOR(R) Fixed-Dose Combination
3. Abbott Initiates Clinical Study to Evaluate Use of RX Herculink(R) Elite(TM) Renal Stent System for the Treatment of Renal Artery Stenosis
4. Abbotts ABT-874 Shows Positive Results for Maintenance of Response in Phase II Psoriasis Study
5. Abbotts XIENCE(TM) V Everolimus Eluting Coronary Stent Shows Continued Superiority to TAXUS Stent in Reducing Major Adverse Cardiac Events in SPIRIT III Clinical Trial
6. Abbott Announces Positive One-Year Results from the Worlds First Clinical Trial of a Fully Bioabsorbable Drug Eluting Coronary Stent
7. Abbotts m2000(TM) Molecular Diagnostic Instrument and RealTime HIV-1 Test Win Chicago Innovation Award
8. Abbotts HUMIRA(R) (adalimumab) Receives FDA Approval For Moderate to Severe Chronic Plaque Psoriasis
9. Abbotts XIENCE(TM) V Drug Eluting Stent Demonstrates Consistent and Positive Clinical Outcomes Out to Two Years
10. Abbotts Phase III Studies of Investigational TriLipix(TM) (ABT-335), in Combination With Statins, Meets Primary Endpoints on Improving LDL, Triglycerides and HDL
11. Study in JAMA Shows Patients Treated With Abbotts XIENCE(TM) V Drug Eluting Stent Experience Better Outcomes Than Patients Treated With Market-Leading Drug Eluting Stent
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/9/2013)... Dec. 9, 2013   Upsher-Smith Laboratories, Inc. ... (PREVAIL) study of USL255 (extended-release topiramate), showing that the ... efficacy and demonstrated favorable safety and tolerability in epilepsy ... presented for the first time at the American ... in Washington, DC , December 6-10, ...
(Date:12/9/2013)... ORLANDO, Fla. , Dec. 9, 2013 ... CADX ), a biopharmaceutical company focused ... products principally for use in the hospital ... new study analyzing large-scale hospital billing data ... healthcare conferences.  The study examined the impact ...
(Date:12/9/2013)... 2013 Laboratory Supply Company (LABSCO), the ... to hospitals, physician office laboratories and alternate healthcare ... & S Medical Associates (J & S). The ... goal to deliver superior diagnostics to the under ... lab markets across the country. ...
Breaking Medicine Technology:Upsher-Smith Debuts Positive Results From Global Phase 3 Study Evaluating USL255 (extended-release topiramate) In Epilepsy Patients With Refractory Partial-Onset Seizures 2Upsher-Smith Debuts Positive Results From Global Phase 3 Study Evaluating USL255 (extended-release topiramate) In Epilepsy Patients With Refractory Partial-Onset Seizures 3Upsher-Smith Debuts Positive Results From Global Phase 3 Study Evaluating USL255 (extended-release topiramate) In Epilepsy Patients With Refractory Partial-Onset Seizures 4Upsher-Smith Debuts Positive Results From Global Phase 3 Study Evaluating USL255 (extended-release topiramate) In Epilepsy Patients With Refractory Partial-Onset Seizures 5New Data Detailing Economic Impact of IV Acetaminophen in Treating Acute Pain to be Presented at Two Major Healthcare Conferences 2New Data Detailing Economic Impact of IV Acetaminophen in Treating Acute Pain to be Presented at Two Major Healthcare Conferences 3New Data Detailing Economic Impact of IV Acetaminophen in Treating Acute Pain to be Presented at Two Major Healthcare Conferences 4LABSCO Acquires J & S Medical Associates 2LABSCO Acquires J & S Medical Associates 3
... Nov. 16, 2011 ZONARE Medical Systems today ... & Sullivan 2011 North American Technology Innovation Award ... the development of Zone Sonography Technology (ZST), the ... one of the industry,s most significant ultrasound breakthroughs. ...
... Nov. 16, 2011 Hotspur Technologies today announced ... Catheter in the United States and select international ... Hotspur,s innovative GPSCath™ Balloon Dilatation Catheter integrates ... physicians to inject contrast during a procedure without ...
Cached Medicine Technology:Frost & Sullivan Honors ZONARE for Ultrasound Innovation 2Hotspur Technologies Commences US Launch at Veith/AIM Conference in New York City 2
(Date:12/10/2013)... 10, 2013 CardioVet has just ... veterinary market. The new CardioVet wireless ECG device ... to rapidly acquire ECG's on their veterinary patients ... servers wirelessly. Clinics submitting ECG's will get ... treatment recommendations from one of CardioVet's board certified ...
(Date:12/10/2013)... December 10, 2013 Dr. Robert Sorenson ... wear removable dentures find a better, permanent solution for ... Sorenson is able to provide patients who have a ... that looks, feels, and performs just like a natural ... see, we find that their lives are more or ...
(Date:12/10/2013)... 10, 2013 Project6 Design, a ... the launch of a responsive website design and ... (CASQA), a leader in the stormwater management field. After ... outreach activities, CASQA.org was bursting at the seams, and ... engaged Project6 Design to refresh the site design and ...
(Date:12/10/2013)... December 10, 2013 A circle ... month with the significant contribution from Minnesota native ... women to come together for their right to ... founder and CEO of the Owatonna-based Learning ... (EPES) Foundation of Chile stretched across the planet ...
(Date:12/10/2013)... Winnipeg, Manitoba (PRWEB) December 10, 2013 America ... 11 developed nations, according to a recent survey that ... survey, which was published in Health Affairs in November, drug ... 50 million Americans, 21 percent, are skipping their medication because ... 9 percent. These numbers are especially concerning when you compare ...
Breaking Medicine News(10 mins):Health News:Midlothian, VA Cosmetic Dentist Dr. Robert Sorenson Introduces Dental Implants as Best Alternative to Removable Dentures 2Health News:Project6 Design Launches Responsive Website Design and Development for California Environmental Nonprofit 2Health News:Project6 Design Launches Responsive Website Design and Development for California Environmental Nonprofit 3Health News:Key Contribution from Melanie Nelson Fosters Health Rights on Two Continents 2Health News:Key Contribution from Melanie Nelson Fosters Health Rights on Two Continents 3Health News:Access and Affordability to Drugs and Healthcare Worst in the U.S. Compared to 10 Other Countries 2
... the American College of Sports Medicine Annual Meeting ... zero sweetener water beverage, developed by researchers for ... as well as a leading sports/electrolyte drink, but ... and artificial ingredients many sports beverages offer consumers. ...
... and vegetables and low in animal products , , FRIDAY, ... Mediterranean diet, which is rich in fruits and vegetables ... developing type 2 diabetes, a Spanish study suggests. , ... to guard against cardiovascular disease, but whether it protects ...
... the,thermometer crept above the 100 degree mark, so ... Harper,s 100-mile-run for the children of,inner-city Sacramento,s roughest ... to raise awareness and support for the uninsured ... crossed the finish line on the playground of ...
... 30 Landauer, Inc. (NYSE:,LDR) announced today that its ... $0.50 per share for the third quarter of fiscal,2008. ... to shareholders of record,on June 13, 2008., About ... services to determine,occupational and environmental radiation exposure. For more ...
... Methods Utilize Cell Phones, E-Mails, and Phone Calls, ... taken per day through a cell phone sounds like ... 55th,Annual Meeting say the technology could be on the ... by Suyi Li, M.S., and Weimo Zhu, Ph.D., FACSM,believe ...
... INDIANAPOLIS, May 30 When a child,experiences ... physical,activity, the default conclusion is that the child ... are several other,explanations for wheezing in pediatric patients ... session at the 55th Annual,Meeting of the American ...
Cached Medicine News:Health News:Zero-calorie Aqua-Lyte hydrates as well as leading sports drink 2Health News:Mediterranean Diet May Ward Off Type 2 Diabetes 2Health News:Mediterranean Diet May Ward Off Type 2 Diabetes 3Health News:Sacramento Man Finished 100-Mile-Run in 100 Degree Heat to Secure Health Care for Uninsured Children 2Health News:Technological Interventions Merge Into Health and Fitness 2Health News:Technological Interventions Merge Into Health and Fitness 3Health News:Pediatric Wheezing: If Not Asthma, Then What is It? 2Health News:Pediatric Wheezing: If Not Asthma, Then What is It? 3
Prevail is a fast-acting, effective antimicrobial gel that makes preoperative preps easier. This unique gel formulation comes in a specifically designed, easy to use applicator for excellent flow con...
The new, single-use 26 mL applicator is latex-free, hands-off and sterile to help prevent cross-contamination. The applicator is designed for a smooth delivery of the solution for larger surgical pro...
These simple but effective single-dose, hands-off, ampulized applicators have revolutionized skin preparation in hospitals....
... Panel consists of plasma specimens with reactivity ... antibodies to the Hepatitis C Virus. ,This ... and diagnostic laboratories to evaluate their anti-HCV ... systems are included for comparative analysis on ...
Medicine Products: